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Mutation of CCM3 causes cerebral cavernous mal-
formations of the vasculature, leading to focal neuro-
logical deficits, seizures, and hemorrhagic stroke.
CCM3 can heterodimerize with GCKIII kinases
(MST3, MST4, and STK25) to regulate cardiovascular
development. Here, we provide direct experimental
evidence to prove that CCM3 heterodimerizes with
GCKIII in a manner structurally resembling the
CCM3 homodimerization. Structural comparison re-
vealed themechanism and critical residues that drive
CCM3-GCKIII heterodimerization versus homodime-
rization. A flexible linker was identified for CCM3,
which mediates a large-scale conformational rota-
tion of the FAT domain relative to the dimerization
domain. The conformational flipover of FAT domain
removes steric locking in the CCM3 homodimer
and allows its disassembly and subsequent hetero-
dimerization with GCKIII. CCM3 forms a stable
complex with MST4 in vivo to promote cell prolifera-
tion andmigration synergistically in a manner depen-
dent on MST4 kinase activity. Collectively, our work
offers a structural basis for further functional study.
INTRODUCTION
The adaptor protein cerebral cavernous malformation 3 (CCM3),
also named programmed cell death 10, is commonly found
mutated in patients with CCMs (Chan et al., 2010; Faurobert
and Albiges-Rizo, 2010; Stahl et al., 2008; Voss et al., 2007).
Major clinical manifestations of CCMs are focal neurological
deficits, seizures, and hemorrhagic stroke (Hasegawa et al.,
2002). Pharmacologic therapy of CCMs has not been effectively
established to date. Animal studies with mice and zebrafish have
revealed that CCM3 plays an essential role in early embryonic
angiogenesis and cardiovascular development (He et al., 2010;
Voss et al., 2009; Yoruk et al., 2012; Zheng et al., 2010). CCM3
interacts with a variety of proteins, including cell adhesion mole-
cule paxillin (Li et al., 2010), membrane receptor vascular
epidermal growth factor receptor 2 (He et al., 2010), CCM
complex component CCM2 (Laberge-le Couteulx et al., 1999;680 Structure 21, 680–688, April 2, 2013 ª2013 Elsevier Ltd All rightsLiquori et al., 2003), and the germinal center kinase III (GCKIII)
family of protein kinases (Ceccarelli et al., 2011; Yin et al.,
2012). Particularly, CCM3-GCKIII signaling facilitates lumen
formation by endothelial cells, which is important during the
progression of CCMs (Chan et al., 2011; Zheng et al., 2010).
The GCKIII kinases include MST3/STK24, MST4/MASK, and
STK25/SOK1/YSK1, which share common adaptor molecules
such as CCM3 (Ceccarelli et al., 2011; Dan et al., 2001; Delpire,
2009; Filippi et al., 2011; Ling et al., 2008). GCKIII kinases are
involved in the regulation of apoptosis, cell proliferation, polarity,
migration, and cytoskeleton remodeling (Ceccarelli et al., 2011;
Fidalgo et al., 2010; Ma et al., 2007; Zheng et al., 2010). For
example, MST4 activates the extracellular signal-regulated
kinase to promote cell growth and transformation in certain cell
lines (Lin et al., 2001; Qian et al., 2001). MST4 appears to be acti-
vated by epidermal growth factor (EGF) and functions down-
stream of the EGF receptor (EGFR) in prostate cancer (Sung
et al., 2003).Meanwhile,MST4 can associatewith the liver kinase
B 1 complex and function upstream of Ezrin during brush border
formation of intestinal epithelial cells (ten Klooster et al., 2009).
CCM3 forms a ternary complex with GCKIII and Golgi matrix
protein GM130 to regulate the Golgi morphology (Fidalgo
et al., 2010; Preisinger et al., 2004). CCM3 also mediates associ-
ation of GCKIII kinases with the protein phosphatase 2A (PP2A)
B00 subunit striatin, forming part of a superamolecular complex
called a ‘‘striatin-interacting phosphatases and kinases’’
complex (Goudreault et al., 2009; Kean et al., 2011). Studies con-
cerning individual knockdown of CCM3 and striatin suggest that
they play opposite roles on Golgi localization of GCKIII member
MST4 (Kean et al., 2011).
CCM3 contains an N-terminal dimerization domain and
a C-terminal focal adhesion targeting (FAT) domain resembling
that of the focal adhesion kinase (FAK) (Ding et al., 2010; Li
et al., 2010, 2011) (Figure 1A). A previous study suggested that
CCM3 forms a heterodimer with GCKIII kinases in a manner
similar to that of CCM3 homodimer (Ceccarelli et al., 2011).
However, it remains to be verified whether this is the case and,
if so, what the mechanism is for CCM3-GCKIII heterodimeriza-
tion versus CCM3 or GCKIII homodimerization.
Here, we have performed structural and functional studies of
the CCM3-MST4 heterodimeric complex, which revealed the
structural mechanism and key residues for CCM3-GCKIII heter-
odimerization, as well as conformational changes needed for
‘‘unlocking’’ of the CCM3 homodimer and subsequent assembly
of the CCM3-GCKIII heterodimer.reserved
Figure 1. Crystal Structure of CCM3-MST4 Complex
(A) Domain architectures of MST4 and CCM3.
(B) In vitro kinase assay using MBP as substrate. Error bars represent SD of data obtained in three independent experiments.
(C) Cartoon views of CCM3 in complex with the dimerization domain of MST4. The dimerization domain and FAT domain of CCM3 are shown in blue and purple,
respectively. A linker region (amino acids 71–97) between these two domains is shown in red. The dimerization domain of MST4 is shown in green.
(D) Hydrophobic residues of CCM3 involved in heterodimerization with MST4. CCM3 and MST4 are shown in cartoon and surface representation, respectively.
(E) Hydrophobic residues of MST4 involved in heterodimerization with CCM3. MST4 and CCM3 are shown in cartoon and surface representation, respectively.
(F) Hydrophilic interactions between CCM3 and MST4 dimerization domain. The magenta dashes represent hydrogen bonds or electrostatic interactions. The
interface residues are labeled and highlighted by stick model. The same color scheme is used for Figures 3 and 4.
See also Figure S1 and 3D Molecular Model S1.
Structure
Structural Study of CCM3-GCKIII HeterodimerizationRESULTS
Overall Structure of the CCM3-MST4 Heterodimer
We chose MST4 as a representative of GCKIII kinases to study
the CCM3-GCKIII heterodimerization and function. To define
a potential role of the CCM3 binding on MST4 kinase activity,
we used purified recombinant proteins to measure the kinase
activity of MST4 toward myelin basic protein (MBP) in the pres-
ence or absence of CCM3 (Figure 1B). Our results showed thatStructure 21CCM3 did not stimulate the kinase activity of MST4 significantly
in vitro.
Using purified recombinant proteins of CCM3 (amino acids
9–212) and MST4 (amino acids 325–413), we reconstituted and
crystallized the heterodimeric complex of CCM3 and MST4 (Fig-
ure 1A; Figure S1 available online). The crystal structures of
CCM3-MST4 heterodimers were determined at 1.95 A˚ using
the single-wavelength anomalous diffraction (SAD) method.
The details of refinement statistics are summarized in Table 1., 680–688, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 681
Table 1. Data Collection and Refinement Statistics
Variable Native Se-Met
Data Collection
Wavelength (A˚) 0.97930 0.97907
Space group P212121 P212121
Cell dimensions
a, b, c (A˚) 75.2, 84.0, 109.7 75.5, 80.0, 109.6
Resolution (A˚) 50.00–1.95 (1.98–1.95)a 50.00–2.40 (2.44–2.40)
Unique reflection 52,288 (2,568) 28,869 (1,420)
Rmerge 0.114 (0.971) 0.096 (0.724)
I/sI 20.6 (2.3) 12.3 (2.2)
Completeness (%) 99.9 (100.0) 99.9 (100.0)
Redundancy 7.2 (7.2) 4.7 (4.9)
Refinement
Resolution (A˚) 45.97–1.95
No. of reflections 48,740
Rwork/Rfree 0.220/ 0.253
No. of atoms
Protein 4,225
Water 174
B factors
CCM3 33.4
MST4 42.7
Water 31.8
Rmsd
Bond lengths (A˚) 0.010
Bond angles () 1.248
aValues in parentheses are for highest resolution shell.
Structure
Structural Study of CCM3-GCKIII HeterodimerizationThere are two copies of 1:1 CCM3-MST4 complex in the asym-
metric unit of the crystals. The structures of the two copies of
heterodimers are essentially the same with a root-mean-square
deviation (rmsd) of 0.94 A˚. Consistent with the previousmodel in-
ferred from sequence alignment (Ceccarelli et al., 2011), the
manner of CCM3-MST4 heterodimerization is structurally remi-
niscent of that of CCM3 homodimerization (Figure 1C). Overall,
the CCM3-MST4 heterodimer is formed by tight hydrophobic
packing between CCM3 and MST4 and further stabilized by
electrostatic interactions, burying a total of 1,603 A˚2 solvent-
accessible surface area. The structures of individual domains
of CCM3 are highly similar to those previously observed (Ding
et al., 2010; Li et al., 2010, 2011). When overlapped, the rmsd
values for the dimerization domain and the FAT domain are
0.77 A˚ and 1.13 A˚, respectively. The structure of the MST4
C-terminal dimerization domain, which is determined for the first
time, consists of three a helices (a1, a2, and a3) in a similar fold
observed for the dimerization domain of CCM3 (Figure 1C), indi-
cating that the MST4 C terminus would homodimerize with
a similar structure.
Details of the CCM3-MST4 Heterodimeric Interface
Similar to CCM3 homodimer, hydrophobic interactions domi-
nate the molecular interface of the CCM3-MST4 heterodimer.
Specifically, residues V25, M26, V29, F30, L33, and V36 in a1-682 Structure 21, 680–688, April 2, 2013 ª2013 Elsevier Ltd All rightshelix; A40, L44, A47, F48, and A51 in a2-helix; L58, I62, I63,
I66, and L67 in a3-helix; and V72, V74, F76, and M83 in a4-helix
of CCM3 (Figure 1D) form hydrophobic core packing with resi-
dues I357, F361, and L364 in a1-helix; I378, L381, I385, and
A388 in a2-helix; and I395, K398, M399, V400, L403, I404, and
F407 in a3-helix of MST4 (Figure 1E).
Besides the hydrophobic core, hydrogen bonding and salt
bridges were observed between a1 and a2 helices of MST4
and a2 and a3 helices of CCM3 (Figure 1F). For example, resi-
dues Q367 in a1-helix and R374 in a2-helix of MST4 interact
with D61 in a3-helix of CCM3 via hydrogen bond and ion pair.
Additionally, residues K65 and K69 in a3-helix of CCM3 interact
with E363 in a1-helix of MST4 through ion or hydrogen bonding.
Residue E54 in a2-helix of CCM3 forms hydrogen bonding with
E380 in a2-helix of MST4. Overall, these electrostatic interac-
tions further stabilized the CCM3-MST4 heterodimer.
Structure-Based Mutational Analyses of the CCM3-
MST4 Heterodimer
To further verify our structural analysis and evaluate the impor-
tance of individual amino acids, we designed a series of CCM3
and MST4 mutants to probe the complex assembly. Wild-type
or mutant Flag-tagged CCM3 and/or Myc-tagged MST4 were
transfected into HEK293T cells for coimmunoprecipitation anal-
ysis. As shown in Figures 2A and 2B, single mutations F361E,
L381D, M399E, L403D, and F407E and four-point mutation
F361E/L381D/M399E/L403D (MST4 Core 4) of MST4, as well
as single mutations M26E, L44D, F48E, and I66D and four-point
mutation M26E/L44D/F48E/I66D (CCM3 Core 4) of CCM3, dis-
rupted the association of MST4 with CCM3. However, mutation
of hydrophilic residue E363A of MST4 or of K50A and E54A of
CCM3 did not abolish the complex formation.
Next, purified recombinant proteins were used to detect inter-
actions between wild-type or mutant MST4 and CCM3 by Octet
Red 96. Single mutations F48E and I66D and four-point mutation
CCM3 Core 4 abolished its interaction with wild-type MST4 (Fig-
ure 2C). Moreover, mutations M26E and L44D, but not K50A and
E54A, of CCM3 markedly reduced its association with MST4
(Figures S2A and S2B). Consistently, mutation of residues L44,
A47, I66, and L67 of CCM3 to aspartic acid residues disrupted
its heterodimerization with MST4 in vitro and in vivo (Ceccarelli
et al., 2011). Meanwhile, single mutations L381D and M399E of
MST4 substantially weakened its interaction with wild-type
CCM3, while four-point mutation MST4 Core 4 abolished its
interaction with wild-type CCM3 (Figure 2D). However, muta-
tions E363A and F407E of MST4 did not significantly alter its
interaction with CCM3 (Figures 2D and S2C). These observa-
tions indicated that the hydrophobic core packing on the inter-
face is required for CCM3-GCKIII heterodimerization.
The CCM3-MST4 Heterodimer Enhances Cell
Proliferation
Previous studies have implicated CCM3 and MST4 in cell prolif-
eration and migration (Fidalgo et al., 2010; Ma et al., 2007; Prei-
singer et al., 2004; Zhu et al., 2010). To gain functional insights
into the CCM3-MST4 complex, we went on to investigate its
cellular effects.
To examine the cell proliferation effect of CCM3-MST4 inter-
action, HeLa cells were transfected with wild-type or mutantreserved
Structure
Structural Study of CCM3-GCKIII HeterodimerizationCCM3 and MST4 and subjected to ATP cell viability assay and
MTT assay. As shown in Figure 2E, transfection with either
CCM3 or MST4 increased proliferative rate by 4-fold in ATP
cell viability assay, compared with empty vector-transfected
cells. Cotransfection of wild-type CCM3 and MST4, but not
complex-disabling or kinase dead mutant, resulted in much
greater proliferative rate, suggesting that CCM3 and MST4
interact with each other to promote cell proliferation synergisti-
cally and that MST4 kinase activity is required for the synergy
effect. These observations are further confirmed by the results
of MTT assay shown in Figure S3.
The CCM3-MST4 Heterodimer Promotes Cell Migration
To evaluate the function of CCM3-MST4 complex on cell
migration, we transfected Ovcar-3 cells with wild-type or
mutant Flag-tagged CCM3 and Myc-tagged MST4, pcDNA
3.1, and Myc-tagged FAK as negative and positive control,
respectively (Figures 2F and S4). It has been well established
that FAK promotes cell migration (Figure S4O) (Sieg et al.,
2000). Our transwell assay showed that wild-type CCM3 as
well as FAK promoted cell migration, while MST4 only had
a moderate effect (Figures S4B and S4C). Various MST4 or
CCM3 mutants had no effect on promoting cell migration
(Figures S4D–S4H). Cotransfection of wild-type CCM3 and
MST4 resulted in a 3-fold enhancement of cell migration,
indicative of a synergistic effect (Figure S4I). Consistently,
interface mutations disrupting complex assembly, as well as
kinase dead mutation, abrogate this synergistic effect of
CCM3 and MST4 on cell migration (Figures S4J–S4N). These
results, together with cell proliferation assays, indicate that
disruption of CCM3-MST4 complex impairs its synergistic func-
tion in cells.
Comparison of the CCM3-MST4 Heterodimer with the
CCM3 Homodimer
Structural comparison of the CCM3-MST4 heterodimer with the
CCM3 homodimer revealed a large-scale conformational rota-
tion of the FAT domain relative to the dimerization domain,
while the structures of both individual domains remain
unchanged (Figures 3 and S5). Detailed examination of the
CCM3 structures identified a flexible linker (amino acids
71–97) between the dimerization domain and the FAT domain,
which accounts for the conformational changes of CCM3.
In the homodimeric structures of CCM3, this linker folds
into a 25-kinked helix (a4-helix) that directly connects the
a3-helix of the dimerization domain to the a5-helix of the FAT
domain (Figures 3A and S5A). However, the helical linker
partially melts into a flexible loop in the CCM3-MST4 complex,
allowing drastic change of the relative orientation between the
FAT domain and the dimerization domain of CCM3 (Figures
S5B–S5D).
It is interesting that the average B factors of the linker region
(amino acids 71–97) are higher than those of other region in
both CCM3 homodimer (Protein Data Bank ID code [PDB]
3L8I) and CCM3-MST4 heterodimer structures (77.4 A˚2 versus
64.1 A˚2 in the CCM3 homodimer; 31.1/48.2 A˚2 versus 27.7/
26.4 A˚2 in two copies of the CCM3-MST4 heterodimers). These
observations indicate that the CCM3 ‘‘linker’’ is flexible in nature
yet may be ‘‘fixed’’ in a specific conformation dependent onStructure 21homo- or heterotypes of association. We speculate that the
specific conformation of the linker region is selectively stabilized
by interactions involving structural domains other than dimeriza-
tion domain itself.
DISCUSSION
Conformational Changes Required for CCM3
Homodimeric Assembly and Disassembly
Consistent with a previous study (Ceccarelli et al., 2011), the
purified recombinant protein of CCM3 forms a stable homo-
dimer, and so does MST4. However, when mixed in vitro, both
CCM3 homodimer and MST4 homodimer disassemble to form
a stable heterodimer. Previous crystallographic studies (Ding
et al., 2010; Li et al., 2010, 2011) have revealed an ‘‘interlocked’’
conformation of the CCM3 homodimer that would block its
disassembly by steric hindrance (Figure 3A). Our structural
comparison of the CCM3-MST4 heterodimer with CCM3 homo-
dimer revealed a conformational ‘‘rotation’’ or ‘‘flipover’’ of the
FAT domain relative to the dimerization domain (Figures 3
and S5), which removes the steric hindrance imposed by the
interlocked conformation.
The conformational flexibility of CCM3 identified here also
sheds some light on the assembly of CCM3 homodimer. Since
there would be apparent steric hindrance preventing CCM3 ho-
modimerization if not for the FAT domain ‘‘flipover,’’ we propose
that CCM3 molecules first assemble into a ‘‘transitional’’ homo-
dimer in which the dimerization domain and FAT domain assume
similar orientation as observed in theCCM3-MST4 complex (Fig-
ure S5B). This transitional CCM3 homodimer then undergoes
conformational reorganization to form an ‘‘interlocked’’ homo-
dimer (Figure 3A), which can be further stabilized by inositol-
(1,3,4,5)-tetrakisphosphate binding between the FAT domains
(Ding et al., 2010; Li et al., 2010, 2011).
Taken together, these observations suggest that the confor-
mational changes of CCM3 are not crystallization artifacts but
instead are required for both assembly and disassembly of the
CCM3 homodimer.
Structural Mechanism of CCM3-GCKIII
Heterodimerization versus CCM3 or GCKIII
Homodimerization
As mentioned, the conformational rotation of the FAT domain
relative to the dimerization domain is required for the disas-
sembly of CCM3 before it can form a heterodimer with GCKIII.
In other words, the FAT domains of the CCM3 homodimer
have to flip over to remove steric hindrance (Figures S5A and
S5B). The CCM3 homodimer then dissociates into monomers,
which directly interact with GCKIII kinases to form heterodimers
(Figures S5C and S5D).
Given the striking three-dimensional similarity between the ho-
modimerization domains of MST4 and CCM3 (rmsd = 0.91 A˚ for
backbone overlapping) (Figures 4A and 4B), we modeled the
structure of the MST4 C-terminal homodimer. It appears that
CCM3 and GCKIII kinases utilized a shared dimerization module
with conserved overall structures to form a homodimer or heter-
odimer (Figures 4C–4E). Thus, an immediate question one may
raise is: what drives the heterodimerization of CCM3-GCKIII
versus CCM3 or GCKIII homodimerization?, 680–688, April 2, 2013 ª2013 Elsevier Ltd All rights reserved 683
Figure 2. Mutational Analysis of CCM3 Association with MST4
(A and B) The indicated constructs of wild-type (WT) or mutant Flag-tagged CCM3 and wild-type or mutant Myc-taggedMST4 were cotransfected into HEK293T
cells. Cells were lysed, andMyc-taggedMST4 was immunoprecipitated (IP) with anti-Myc antibody and subjected to immunoblot (IB) analysis. WB, western blot.
(C and D) Interactions of wild-type or mutant MST4 with wild-type or mutant CCM3 determined by Octet Red 96. Response for MST4 binding to CCM3 was
plotted against MST4 concentration. The response unit (RU) was 1 nm.
(E) HeLa cells were transfected with indicated constructs of wild-type or mutant Flag-tagged CCM3 or/and wild-type or mutant Myc-tagged MST4. Cell
proliferation was evaluated by ATP cell viability assay. The percentage of viable cells in control (empty vector) was set to 1.0. Error bars represent SD of data
obtained in three independent experiments.
(legend continued on next page)
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Figure 3. Overall Structural Comparison of
CCM3 Homodimer with CCM3-MST4 Heter-
odimer
(A) CCM3 forms homodimer through the dimer-
ization domain (PDB 3L8I). One monomer of
CCM3 is colored the same as in Figure 1C, and the
other monomer is shown in yellow. The linker
region connecting the dimerization domain, and
the FAT domain largely folds into a helix.
(B) CCM3 forms a heterodimer with MST4 via their
dimerization domains. The linker region of CCM3
undergoes a conformational change, with its
helical structure partially melting into a flexible
loop in the CCM3-MST4 heterodimer.
See also Figure S5.
Structure
Structural Study of CCM3-GCKIII HeterodimerizationTo address this question, we performed an in-depth structural
analysis of the CCM3-MST4 heterodimer and CCM3 or MST4
homodimers. The homodimers of CCM3 and MST4 dimerization
domains have 1,150.7 A˚2 and 1,365.6 A˚2 buried surface areas,
respectively. The heterodimer of CCM3-MST4 has a buried
surface area in similar size (1,394.2 A˚2), suggesting that addi-
tional factors may account for the heterodimerization versus
homodimerization.
Distinct from the CCM3 or GCKIII homodimers, the CCM3-
GCKIII heterodimer has a 2-fold pseudosymmetry. Compared
with CCM3, GCKIII kinases have an inserted loop between
helices a1 and a2 (Figure 4A). Residues R374 and Q367 in
this insertion loop of MST4 form an ion pair and hydrogen
bond with residue D61 of CCM3 (Figure 4F). Correspondingly,
the pseudosymmetry-related residues V36 of CCM3 and
K396 of MST4 also form hydrophobic contacts. These interac-
tions appear to specifically stabilize the CCM3-MST4 hetero-
dimer because no equivalent interactions were observed in
either CCM3 or MST4 homodimers (Figure 4G). In the case
of CCM3 homodimer, residue V36 from one protomer is corre-
sponding to residues R374 and Q367 of MST4 and does
not interact with D61 from the other protomer. Similarly, the
residue corresponding to D61 of CCM3 was substituted with
K398 in the case of MST4 homodimer. Moreover, we found
all these key residues are conserved across species (Fig-
ure S6A), further indicating their importance for CCM3-GCKIII
heterodimerization.
To further assess the importance of residues Q367, R374, and
K396 of MST4 for heterodimerization with CCM3, we compared
the sequences of GCKIII kinases and found that these key resi-
dues were substituted with K390, N397, and T421 in MST3,
respectively, which would structurally predict a less stable heter-
odimer between MST3 and CCM3 (Figure 4A). Indeed, we found
by in vitro gel filtration assay thatMST4, but notMST3, copurified
with CCM3 in one symmetric elution peak, which is consistent
with previous studies showing that MST3 has a weaker binding
affinity with CCM3 in vivo when compared with MST4 (Fidalgo
et al., 2010; Zheng et al., 2010) (Figures S6B and S6C). Pull-
down assay further confirmed that the association of CCM3(F) Ovcar-3 cells were transferred with indicated constructs of wild-type or mutan
chamber to the bottom surface of the inserts. Cells thenwere fixedwith 4% formal
control (empty vector) was set to 1.0. Error bars represent SD of data obtained i
See also Figures S2–S4.
Structure 21withMST4 ismore stable thanwithMST3 (Figure S6D). To further
quantify these observations, we performed kinetic analysis for
CCM3-MST3 interactions using Octet Red 96. Compared with
MST4, MST3 showed a weaker binding affinity to CCM3, with
a Kd of 24.3 nM (about 2-fold of that for CCM3-MST4 binding)
(Figure S6E).
Functional Implications of the CCM3 Heterocomplex
with GCKIII Kinases
Overexpression of CCM3 alone or MST4 alone promoted cell
proliferation as well as cell migration. However, overexpression
of both CCM3 and MST4 greatly enhanced these effects.
CCM3 and MST4 form a complex to promote cell proliferation
and migration synergistically, but mutants disabling MST4
kinase activity could not do so, suggesting that the kinase
activity of MST4 is required for these cooperative functions.
As we did not observe significant stimulation effect of CCM3
on MST4 activation in vitro, therefore CCM3 may also regulate
MST4 function independent of its kinase activity. Further
studies are required to identify and dissect the mechanism
through which CCM3 and MST4 induce cell proliferation and
migration.
CCM3 was first identified in an human apoptotic myeloid cell
line (Wang et al., 1999) and then correlated with tumor progres-
sion (Aguirre et al., 2004; Huerta et al., 2003). Differential or even
opposite cellular functions have been identified for CCM3 (Chen
et al., 2009; Zhu et al., 2010). The mechanism of how CCM3
performs multiple biological functions, such as prosurvival or
proapoptotic signaling, remains largely unknown. Our results
suggested that distinct members of GCKIII kinases bind to
CCM3with differential affinities due to variations of residues crit-
ical for heterodimerization. In this regard, it is worth noting that
GCKIII kinases also have differential cellular functions. MST4
promotes proliferation in certain cell lines while inducing
apoptosis in others (Dan et al., 2002; Lin et al., 2001; Ma et al.,
2007; Sung et al., 2003; ten Klooster et al., 2009). MST3 and
STK25 are involved in caspase-dependent or independent
apoptosis (Huang et al., 2002; Lin et al., 2010; Nogueira et al.,
2008).t CCM3 or/and wild-type or mutant MST4. Ovcar-3 cells migrated from the top
dehyde and stained with three-step stain set. The percentage of migrated cell in
n three independent experiments.
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Figure 4. Key Residues Driving CCM3-GCKIII Heterodimerization versus Homodimerization
(A) Sequence alignment for dimerization domains of CCM3 and GCKIII kinases. The secondary structures of CCM3 and MST4 dimerization domain are labeled.
Highly conserved residues between CCM3 and GCKIII are shown in red. Additional residues conserved in GCKIII are boxed in blue. The key residues for het-
erodimerization are highlighted with red shadow and indicated with asterisks. The residues involved in homodimerization and heterodimerization are highlighted
with bold and italic characters.
(B) Structural superposition of CCM3 and MST4 dimerization domains.
(C) Structure of CCM3-MST4 heterodimer determined in this work.
(D) Structure of CCM3 N-terminal homodimer (PDB 3L8I).
(E) Modeled structure of MST4 C-terminal homodimer.
(F and G) Comparison of the CCM3-MST4 heterodimer with the CCM3 or MST4 homodimer. The heterodimer structure has a 2-fold psudosymmetry, while the
homodimeric structures of CCM3 andMST4 are symmetrical. Note that the specific intermolecular interactions mediated by key residues R374, Q367, and K398
of MST4 and V36 and D61 of CCM3 are only present in CCM3-MST4 heterodimer (F) but not in CCM3 or MST4 homodimer (G).
See also Figure S6.
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Structural Study of CCM3-GCKIII HeterodimerizationEXPERIMENTAL PROCEDURES
Purification and Structure Determination
The native and selenomethionine (Se-Met)-substituted human CCM3 (amino
acids 9–212) and MST4 (amino acids 325–413) were copurified by affinity
and gel filtration chromatography. The complex was cocrystallized in 2% Tac-
simate, pH 6.0, 0.1 M BIS-TRIS, pH 6.5, 18% (w/v) PEG 3350. Diffraction data686 Structure 21, 680–688, April 2, 2013 ª2013 Elsevier Ltd All rightswere collected at beamline BL17U, Shanghai Synchrotron Radiation Facility
(SSRF), China. The complex structure was solved using the SAD method.
In Vitro Kinase Assay
The activity of recombinant MST4 and its mutants were assayed by usingMBP
as substrate. One unit of protein kinase activity is that amount that catalyzes
the incorporation of 1 nmol phosphate into MBP in 1 min.reserved
Structure
Structural Study of CCM3-GCKIII HeterodimerizationInteraction Analysis
The interaction detection was performed using the Octet Red 96 (ForteBio).
Biotinylated wild-type or mutant CCM3 were immobilized on the streptavidin
biosensors and incubated with varying concentrations of wild-type or mutant
MST4.
Coimmunoprecipitation
HEK293T cells were transiently with expression vectors encoding wild-type or
mutant Flag-tagged CCM3 or/andMyc-taggedMST4. Cell extracts were incu-
bated with anti-Myc antibody and protein A/G agarose (Santa Cruz Biotech-
nology). The immune complexes were subjected to SDS-PAGE and analyzed
by western blotting.
Cell Proliferation Assay
HeLa cells were transfected with the indicated plasmids of pcDNA3.1, or wild-
type or mutant Flag-tagged CCM3 or/andMyc-taggedMST4. ATP cell viability
assay and MTT assay were used for detection cell proliferation.
Cell Migration Assay
Ovcar-3 cells were transfected with pcDNA3.1, wild-type or mutant Flag-
tagged CCM3 or/and Myc-tagged MST4, or Myc-tagged FAK for 24 hr. Cells
that migrated through and to the bottom surface of the inserts were fixed with
4% formaldehyde and stained with a three-step stain set.
ACCESSION NUMBERS
The structural coordinates of the CCM3-MST4 complex were deposited in the
PDB under the ID code 4GEH.
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Supplemental Information includes six figures, one 3D molecular model, and
Supplemental Experimental Procedures and can be found with this article
online at http://dx.doi.org/10.1016/j.str.2013.02.015.
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